PETER T. WHITE, MD

Plain English
This study looked at patients who had their thymus gland removed (thymectomy) to see if they developed new cancers or autoimmune diseases afterward. Out of 226 patients, 13 (or 6%) developed new cancers, which is similar to the general population's rate of 0.81%. However, 19 patients (or 8%) received new diagnoses of autoimmune diseases, which is higher than the average rate of 0.7% seen in the general population. Who this helps: This information benefits doctors and patients considering thymectomy, especially those with autoimmune disorders.

Plain English
This study compared two surgical methods, per oral endoscopic myotomy (POEM) and laparoscopic Heller myotomy (LHM), for treating a specific type of swallowing disorder called type III achalasia. Researchers looked at 46 patients and found that both methods led to similar success rates, with 87.5% of POEM patients and 86.7% of LHM patients reporting significant symptom relief. Additionally, about 25% of POEM patients needed further treatment compared to 16.7% of LHM patients, but this difference wasn’t significant. Who this helps: This information benefits patients with type III achalasia and their doctors by confirming that both surgical options are effective for treatment.

Plain English
This study looked at two different surgical methods for treating large paraesophageal hernias (PEHs) without significant reflux: one that uses gastropexy and another that combines gastropexy with fundoplication. Researchers found that the rates of hernia reoccurrence were 14.6% for the gastropexy group and 20.5% for the fundoplication group, which is similar, and both groups had low levels of reflux symptoms after surgery. This matters because it indicates that gastropexy alone can be a viable option for certain patients, potentially simplifying the procedure. Who this helps: Patients with large paraesophageal hernias who do not have significant reflux.

Plain English
This study looked at complications from laparoscopic surgeries for fixing reflux problems and hiatal hernias, specifically comparing patients who had these surgeries redone (revisional) to those who had them for the first time (primary). Researchers found that while the overall rate of complications at 30 days was similar for both groups, patients who had revisional surgery experienced more severe complications at 90 days, with 7.1% facing issues compared to just 2.0% in the primary surgery group. This matters because it highlights the increased risks involved in revisional surgeries, helping healthcare providers assess and manage patient care more effectively. Who this helps: This information benefits doctors and surgeons who perform these procedures.

Plain English
This study looked at the outcomes of patients who had large thymomas (tumors in the thymus gland) removed using robotic surgery. Out of 40 patients with thymomas larger than 5 centimeters, only 4% experienced a recurrence of the cancer and 5% died within five years after surgery. The results showed that robotic surgery for large thymomas is as effective as traditional open surgery in terms of recurrence and survival rates. Who this helps: This research benefits patients with thymomas, especially those considering robotic surgery.

Plain English
This study examined the long-term effects of a surgical technique called diaphragmatic relaxing incisions during hernia repairs in the stomach area. Researchers compared 125 patients who had this incision with a matched group that did not, finding similar recurrence rates of hernias (24% versus 26%) and quality of life scores regarding reflux issues after about five years. This is important because it shows that using these incisions does not provide added benefit compared to repairs done without them. Who this helps: This helps patients undergoing hiatal hernia repairs by providing clear information on the effectiveness of different surgical techniques.

Plain English
This study looked at how community health workers (CHWs) help adults with type 2 diabetes manage their blood sugar levels. It found that after at least a year of working with CHWs, participants had a notable drop in their HbA1c levels, averaging a reduction of 0.50% compared to those receiving standard care. This matters because lower HbA1c levels indicate better diabetes control, which can lead to fewer health complications, especially in low-income, minority groups. Who this helps: This helps patients with type 2 diabetes, particularly those from minority ethnic groups on low incomes.

Plain English
This study examined how well patients with esophageal cancer adhered to guidelines for a specific treatment called nivolumab after surgery. Out of 73 eligible patients, 67 (92%) were offered nivolumab, and 57 (85%) started the treatment; however, only 25 (48%) completed the full year of therapy. The findings show that while most doctors are following the treatment guidelines, patients in less affluent communities are less likely to be offered this therapy, and completing the year-long treatment is more common among those with certain cancer characteristics. Who this helps: This research benefits patients with esophageal cancer and the doctors treating them.

Plain English
This study looked at how the leftover cancer after treatment affects survival and recurrence in patients with esophageal adenocarcinoma. Among 504 patients followed for over five years, those who had no remaining cancer cells in their lymph nodes had significantly lower survival rates: 68.3% for those with only esophageal cancer left, compared to just 20.1% for those with more extensive lymph node involvement. These findings emphasize the importance of where the remaining cancer is located for predicting patient outcomes after treatment. Who this helps: This research benefits patients with esophageal cancer and their doctors by providing insights on how to better assess treatment effectiveness.

Plain English
This study looked at the risks of complications and death following surgeries for acid reflux and hiatal hernias by analyzing data from 2,342 patients. It found that within 30 days after surgery, 18.2% of patients had complications, but only 0.2% died. Most complications were minor, and the rates decreased significantly from 31 to 90 days, with only 3.1% experiencing issues during that period. Who this helps: This information helps patients and doctors understand the risks involved in these surgeries.

Plain English
This study examined the risks of complications after antireflux and hiatal hernia surgeries in patients of various ages, analyzing over 2,300 cases from 2003 to 2020. Researchers found that 18.2% of patients experienced complications within 30 days, with the risk increasing significantly from 13.5% in patients under 60 to 35% in those 80 and older. While most complications were minor, the data highlight the need for careful consideration of age when planning these surgeries. Who this helps: Patients and their doctors can make better-informed decisions about surgery based on age-related risks.

Plain English
This study looked at different shapes of the openings in the diaphragm (hiatus) related to hiatal hernias and how these shapes influence surgery complexity and the chance of hernias coming back after treatment. Researchers reviewed data from 239 patients and found that 47% of them experienced a recurrence of the hernia. While more complex shapes indicated a need for advanced surgical techniques, these shapes did not directly affect the likelihood of recurrence. Who this helps: This helps surgeons and patients dealing with hiatal hernias by providing insights into surgical planning.

Plain English
This study compared two types of surgery used to treat gastroesophageal reflux disease (GERD): magnetic sphincter augmentation (MSA) and Nissen fundoplication (NF). Researchers looked at 523 patients and found that, after one year, both surgeries similarly improved patients' quality of life scores and proton pump inhibitor use, with MSA showing a decrease from 14% to 5% compared to NF's decrease from 24% to 5%. However, MSA had higher reoperation rates (10% vs. 4%) and a higher occurrence of recurrent hiatal hernias (18% vs. 7%), which is important for patients considering their options. Who this helps: This information helps patients with GERD decide between surgical options and understand potential outcomes.

Plain English
This study compared two treatments for complicated pleural infections: a drug therapy using tissue plasminogen activator and deoxyribonuclease versus surgical removal of infected tissue. Out of 26 patients, everyone completed the study, and treatment failure occurred in only one patient from the drug therapy group. Importantly, while patients treated with the drug therapy had longer hospital stays on average (11 days compared to 5 days for surgery), these results were similar in terms of complications and reoperations, showing that both methods are viable options. Who this helps: This research helps patients with complicated pleural infections by exploring effective treatment options.

Plain English
This study looked at the outcomes of patients with stage IIIA-N2 non-small cell lung cancer (NSCLC) who still had N2 disease after receiving initial treatment. Out of 54 patients, 31 (57%) had persistent N2 disease, while 23 (43%) showed improvement. Those with complete resection (R0) had a median survival of 69 months, compared to 26 months for uncertain resection (R(un)), showing that surgery can be beneficial even if N2 disease persists. Who this helps: This information benefits lung cancer patients and their doctors by providing evidence for considering surgery as a treatment option.

Plain English
This study looked at patients with mild to moderate chronic obstructive pulmonary disease (COPD) who were using inhaled corticosteroids (ICS) to see if it was practical to stop the medication and if patients were okay with that decision. Out of nearly 3,000 COPD patients, 149 were invited to participate, and 61 agreed to either stop or continue their ICS treatment. They found that 45% of those who stopped taking ICS showed signs of asthma that hadn't been previously documented, which means doctors need to closely monitor these patients after any change in their medication. Who this helps: This benefits COPD patients in primary care who may not need ICS and helps their doctors make better treatment decisions.

Plain English
This research focuses on how cardiothoracic training programs adapted their interview processes to a virtual format due to the COVID-19 pandemic. The findings indicate that new online techniques, like social media promotion and virtual tours, not only worked well during the pandemic but are likely to remain relevant even after it ends. This is important because it helps programs effectively showcase their strengths to potential applicants while also addressing traditional barriers related to finances and scheduling. Who this helps: This benefits medical trainees and candidates applying for cardiothoracic programs.

Plain English
This study analyzed a program called the Johns Hopkins Initiative for Careers in Science in Medicine, designed to help students from low-income backgrounds succeed in medical and biomedical fields. The program has significantly helped high school scholars, with 83% continuing to four-year colleges, and of those, 73% pursuing STEMM majors. Among undergraduate participants, 42% have entered medical or biomedical graduate programs, while 71% of post-baccalaureate scholars are now in doctoral-level programs. Who this helps: This benefits students from under-resourced backgrounds aspiring to medical and science careers.

Plain English
This study examined how new drugs that inhibit a protein called HSP90 can impact triple-negative breast cancer (TNBC), particularly targeting cancer stem cells that help tumors grow and spread. The researchers found that two drugs, KU711 and KU758, reduced markers of these cancer stem cells by 50-80% and significantly decreased tumor growth in mouse models—tumor size was cut down by about half with KU758 and by 75% with KU711, without causing harm to healthy cells. This is important because it shows a new way to potentially stop the most aggressive forms of breast cancer from spreading and recurrently returning. Who this helps: This helps patients with triple-negative breast cancer by providing new treatment options.

Plain English
Researchers studied a new way to deliver a drug called withalongolide A, which is effective against triple-negative breast cancer, by using a special nanoparticle that targets a specific receptor called scavenger receptor B1 found in high amounts in these cancer cells. They found that this method led to a 54% reduction in tumor size in mice compared to standard treatments. This is important because it shows a more effective approach to treating a hard-to-treat cancer, providing hope for better outcomes. Who this helps: This helps patients with triple-negative breast cancer.

Plain English
The study looked at COPD patients who were prescribed inhaled corticosteroids (ICS) despite guidelines suggesting they might not need them. Out of a large group of nearly 210,000 patients, only 39% were found to be appropriate candidates to stop using ICS, primarily because of issues like frequent flare-ups and reversible lung obstruction. This matters because properly identifying who can safely stop using these medications can help prevent unnecessary treatments and side effects. Who this helps: This helps COPD patients and their doctors by guiding better treatment decisions.

Plain English
This is a case report describing a rare patient who developed both an intercostal hernia and a diaphragmatic hernia simultaneously after a sneezing episode, an extremely uncommon combination of injuries. Surgical repair through the chest was performed successfully. The case illustrates that minor straining events can cause significant thoracic hernias in susceptible individuals.

Plain English
This study looked at a new way to deliver a cancer-fighting drug to neuroblastoma cells, a type of cancer that mainly affects young children. Researchers created a special delivery system using synthetic high-density lipoprotein nanoparticles to transport the drug 4,19,27-triacetyl withalongolide A, which was found to be 1,000 times more effective at killing cancer cells than the carrier alone. This approach significantly reduced the cancer stem cells' ability to grow and spread, showing promise for better treatment options. Who this helps: This helps patients with neuroblastoma by potentially providing more effective treatment options.

Plain English
This study looked at readmission rates for patients with chronic obstructive pulmonary disease (COPD) in London, analyzing data from over 38,000 hospital admissions between 2006 and 2010. They found that about 32% of patients were readmitted within a year, with 10% returning within 30 days and 17.8% within 90 days. The findings indicate that readmission rates are lower than previously thought, suggesting there may not be significant opportunities to prevent further readmissions. Who this helps: This helps patients with COPD and their healthcare providers by clarifying readmission risks.

Plain English
This study looked at a new way to deliver a drug called withalongolide A 4,19,27-triacetate (WGA-TA) to treat adrenocortical carcinoma (ACC), a rare cancer with a low survival rate. Researchers created special tiny carriers (nanodisks) that effectively delivered WGA-TA directly to ACC cells, achieving a drug delivery efficiency of 78% and making it significantly more toxic to cancer cells compared to the drug alone. This is important because it could lead to more effective treatments for ACC, improving outcomes for patients. Who this helps: Patients with adrenocortical carcinoma.

Plain English
This study explored new drugs called HSP90 inhibitors to see if they could stop thyroid cancer stem cells from moving and spreading in the body. The researchers found that two of these drugs, KU711 and WGA-TA, significantly reduced the cancer stem cell activity, with WGA-TA decreasing movement by up to 100% and reducing the ability to form tumors by 64-99%. This is important because it shows potential new treatments could help control aggressive thyroid cancers. Who this helps: This benefits patients with thyroid cancer, particularly those with aggressive forms of the disease.

Plain English
This study looked at the physical abilities of 87 patients with severe osteoarthritis who were waiting for knee replacement surgery and compared them to 60 patients with mild osteoarthritis. The research found that patients with severe osteoarthritis performed significantly worse on various physical tests and reported different levels of pain compared to those with mild osteoarthritis. These findings are important because they highlight the need for better assessments of physical function in patients with severe osteoarthritis to improve treatment decisions. Who this helps: This helps patients waiting for knee replacement surgeries and their doctors.

Plain English
This study looks at natural compounds called withanolides, specifically those from the Withania somnifera plant, which have been used in traditional medicine for thousands of years. The research highlights their anti-inflammatory effects and explains how they could help treat chronic diseases like arthritis, autoimmune conditions, and cancer, showing promising results with few side effects. It matters because these compounds offer potential new treatment options for patients suffering from difficult-to-treat conditions. Who this helps: This helps patients with chronic inflammatory diseases.

Plain English
Researchers studied a drug called sorafenib to treat advanced thyroid cancer that doesn’t respond to standard radioactive iodine therapy. They found that sorafenib significantly improves progression-free survival for these patients, meaning they live longer without the disease worsening, although it's not clear yet if it increases overall survival. This matters because it offers a new treatment option for patients with difficult-to-treat thyroid cancer, despite some side effects and costs associated with the drug. Who this helps: This helps patients with advanced thyroid cancer that does not respond to radioactive iodine.

Plain English
This study looked at hospital stays for patients with Chronic Obstructive Pulmonary Disease (COPD) in London from 2006 to 2010. Researchers found that the average length of stay for the first hospital admission decreased from 8.2 days to 7.0 days, and most patients (79%) were discharged within 10 days. However, there were big differences between hospitals, with some having nearly 5 days longer stays than others, which indicates that standardizing care could improve patient recovery and reduce healthcare costs. Who this helps: This benefits patients with COPD and healthcare providers.

Plain English
Researchers found that cells in the joints of people with rheumatoid arthritis (a disease where the immune system attacks joints) produce a protein called B7-H3 that helps activate immune cells called T cells. When they reduced B7-H3 levels in lab experiments, T cells behaved differently depending on whether they were already activated or not—resting T cells made more inflammatory chemicals, while already-activated T cells made fewer. This discovery matters because B7-H3 could be a new target for treating rheumatoid arthritis and possibly other inflammatory diseases.

Plain English
This study looked at whether taking selenium supplements could help adults with asthma improve their quality of life and lung function. Researchers involved 197 participants who took either a selenium supplement or a placebo for 24 weeks. Although the selenium levels in those taking the supplement increased by 48%, there was no significant improvement in asthma symptoms or quality of life compared to those taking the placebo. Who this helps: This research helps doctors and patients understand that selenium supplementation does not improve asthma symptoms.

Plain English
Researchers studied how immune cells called T cells interact with joint lining cells in rheumatoid arthritis, using microscopy to watch these interactions happen in real time. They found that a specific type of activated T cell sticks tightly to joint cells and triggers them to produce inflammatory chemicals, and this process depends on a protein called TNF-alpha on the T cell's surface. This discovery explains why TNF-alpha blocking drugs are so effective at treating rheumatoid arthritis—they literally stop the inflammatory conversation between immune cells and joint tissue.

Plain English
This study looked at how general practitioner (GP) teachers feel about a new program that would allow them to observe each other's teaching. Most of the GP teachers (69%) thought that this peer observation could help improve the education of future doctors, but less than half wanted to participate, mainly due to concerns about time, paperwork, and feeling watched. The findings indicate that fear of criticism is a big barrier that needs to be addressed for the program to work effectively. Who this helps: This helps GP teachers and ultimately benefits medical students.

Plain English
This study looked at how morning lung function (measured by peak expiratory flow, or amPF) relates to asthma symptoms throughout the day in adults with asthma. The researchers found that in only 16% of patients, there was a strong connection between morning lung function and daily symptoms, while for the group as a whole, the relationship was much weaker. This highlights that relying solely on morning peak flow measurements to manage asthma symptoms may not be effective for most patients. Who this helps: This helps patients with asthma and their doctors.

Plain English
This study examined intestinal worm infections in 1,820 school children in Njala, Sierra Leone. It found that 33.3% had a common type of worm called Ascaris lumbricoides, while 14.6% had Trichuris trichiura, and 10.4% had hookworm infections. Many children were affected by multiple infections: over half had one, 40% had two, and 6.9% had three or more types of worms. Regular screenings in schools can help with early detection and treatment of these infections, which is crucial for improving children's health. Who this helps: This helps school children and healthcare providers in Sierra Leone.

Plain English
This study looked at why children in New Zealand are more likely to die from asthma and go to the hospital compared to those in the UK. Researchers found that asthma deaths among Kiwi kids aged 5-14 were 2.5 times higher than in England, and symptoms like wheezing were notably more common in Auckland. Interestingly, even though New Zealand had fewer hospital admissions for asthma, the higher death rate seems linked to more severe asthma cases rather than poorer medical care. Who this helps: This information benefits patients, their families, and healthcare providers by highlighting the need for better asthma management in New Zealand.

Plain English
This study looked at whether small group education for general practitioners (GPs) could improve the management of asthma in their patients. After involving 27 GPs and over 450 patients in a structured program of meetings, researchers found that there was no change in asthma-related health problems or medication use among patients in any of the groups after two and a half years. This matters because it shows that just educating doctors in a group setting did not help reduce asthma issues, indicating that more tailored approaches may be needed. Who this helps: This helps doctors and healthcare organizations understand the limitations of group education for managing chronic diseases like asthma.

Plain English
Researchers studied the infection rate of Onchocerca volvulus, a parasite that causes river blindness, in the Nimiyama Chiefdom of Sierra Leone. Out of 735 people tested, 471 were infected, which means a whopping 64% infection rate, with a higher number of infections among males (70%) compared to females (56%). This matters because it highlights the significant public health issue in the region, where the risk of infection rises with age. Who this helps: This helps patients in Sierra Leone by highlighting the need for better prevention and treatment efforts.

Plain English
This study looked at the connection between newly developed rice swamps and two diseases, schistosomiasis and onchocerciasis, in 74 villages in eastern Sierra Leone. Schistosomiasis was found to have low but widespread infection rates, while onchocerciasis affected nearly 50% of people in all villages studied. The research suggests that while the rice swamps are not likely to increase these diseases, there is a pressing need for a control program for onchocerciasis, a significant health issue in rural areas. Who this helps: This helps patients in rural Sierra Leone who are at risk of onchocerciasis.